← Back to headlines
Vertex Pharmaceuticals climbs on positive interim data from IgAN phase 3 trial
Vertex Pharmaceuticals stock is rising following the release of positive interim data from its Phase 3 clinical trial for IgAN.
10 Mar, 08:50 — 10 Mar, 08:50
Sources
Showing 1 of 1 sources
Related Stories
Pofonegyszerű módszerrel lehet lassítani a biológiai óra ketyegését
4m ago
Gydytojas paaiškino, ką gali reikšti, jei pavalgius visada prispiria „reikalas“
6m ago
Key fitness measure is strong predictor of longevity after certain age, study finds
6m ago
Αυτή η συνήθεια μπορεί να κάνει τα μαλλιά να ασπρίσουν πιο γρήγορα, ακόμη και πριν τα 30
11m ago